Cargando…
Therapeutic Strategies for Mutant SPAST-Based Hereditary Spastic Paraplegia
Mutations of the SPAST gene that encodes the microtubule-severing enzyme called spastin are the chief cause of Hereditary Spastic Paraplegia. Growing evidence indicates that pathogenic mutations functionally compromise the spastin protein and endow it with toxic gain-of-function properties. With eac...
Autores principales: | Mohan, Neha, Qiang, Liang, Morfini, Gerardo, Baas, Peter W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8394973/ https://www.ncbi.nlm.nih.gov/pubmed/34439700 http://dx.doi.org/10.3390/brainsci11081081 |
Ejemplares similares
-
Reduced acetylated α-tubulin in SPAST hereditary spastic paraplegia patient PBMCs
por: Wali, Gautam, et al.
Publicado: (2023) -
Truncating mutations of SPAST associated with hereditary spastic paraplegia indicate greater accumulation and toxicity of the M1 isoform of spastin
por: Solowska, Joanna M., et al.
Publicado: (2017) -
A patient-derived stem cell model of hereditary spastic paraplegia with SPAST mutations
por: Abrahamsen, Greger, et al.
Publicado: (2013) -
Hereditary Spastic Paraplegia with a Novel SPAST Mutation Misdiagnosed with Subacute Combined Degeneration
por: Yang, Ji Won, et al.
Publicado: (2013) -
A patient-derived stem cell model of hereditary spastic paraplegia with SPAST mutations
por: Abrahamsen, Greger, et al.
Publicado: (2015)